News | Venous Therapies | February 22, 2021

FDA Clears Zilver Vena Venous Self-Expanding Stent

FDA Clears Zilver Vena Venous Self-Expanding Stent

February 22, 2021 — The U.S. Food and Drug Administration (FDA) recently cleared the Cook Medical Zilver Vena Venous Self-Expanding Stent to treat the iliofemoral vein. 

The device is used to reopen narrowed regions of iliofemoral veins caused by a collection of fibrous blood clots that can form along the walls of veins following deep-vein thrombosis (DVT, or post-thrombotic syndrome) or caused by the squeezing of the vein between a bone and an overlying artery (iliofemoral compression). These conditions may limit blood flow from the leg and lead to swelling and pain in the leg when walking.

The stent is made of nitinol (nickel-titanium) and comes on and over-the-wire stent delivery system.

In clinical studies, 89.9% of patients who received the Zilver Vena Venous Self-Expanding Stent continued to have an open iliofemoral vein after one year.

The stent should not be used in patients who have a lesion that prevents crossing or complete inflation of an angioplasty balloon or proper placement of the stent or stent delivery system. It also should not be used in patients who cannot receive specific blood thinning medications, such as aspirin or warfarin.

For more information on this device from the FDA website: https://www.accessdata.fda.gov/cdrh_docs/pdf20/P200023B.pdf

Product website: https://www.cookmedical.com/products/f3af274c-42cc-42cd-a0db-e5715ad57cc4/


Related Content

News | Cath Lab

May 16, 2023 — Royal Philips, a global leader in health technology, announced late-breaking data from the DCR4Contrast ...

Home May 16, 2023
Home
News | Cath Lab

March 14, 2023 — Royal Philips, a global leader in health technology, and the Gibraltar Health Authority, announced they ...

Home March 14, 2023
Home
News | Cath Lab

March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...

Home March 01, 2023
Home
News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
Subscribe Now